Ocular microvascular alteration in Sjögren's syndrome treated with hydroxychloroquine: an OCTA clinical study.

"The authors declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article."

"Funding: The authors disclosed receipt of the following financial support for the research, authorship, and/or publication of this article: National Natural Science Foundation (grant no: 82160195); Central Government Guides Local Science and Technology Development Foundation (grant no: 20211ZDG02003); Key Research Foundation of Jiangxi Province (grant nos: 20181BBG70004 and 20203BBG73059); Excellent Talents Development Project of Jiangxi Province (grant no: 20192BCBL23020); Natural Science Foundation of Jiangxi Province (grant no: 20181BAB205034); Grassroots Health Appropriate Technology ‘Spark Promotion Plan’ Project of Jiangxi Province (grant no: 20188003); Health Development Planning Commission Science Foundation of Jiangxi Province (grant no: 20201032 and 202130210); Health Development Planning Commission Science TCM Foundation of Jiangxi Province (grant no: 2018A060 and2020A0087)."